CoChat

Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis: A Putative Role for the Corticosteroid Receptor β Isoform

CHIKANZA, IAN C. · 2002 · Annals of the New York Academy of Sciences
Cited by 87

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

A bstract: Corticosteroids (CSs) have potent immunosuppressive effects and are commonly used to treat a range of immunological and inflammatory diseases such as rheumatoid arthritis (RA). These effects are mediated by the ability of CSs to modulate gene expression. CSs act by binding to the CS receptor (CR), which exists as α and β isoforms. Only CRα binds CS. CRβ functions as an endogenous inhibitor of CS and is expressed in several tissues. The CS/CRα complex binds to the glucocorticosteroid response element in the nucleus and also interferes with AP‐1 and NF‐κB binding. Thus, CSs inhibit the transcription of AP‐1 and NF‐κB inducible genes, such as interleukin (IL)‐2, IL‐6, IL‐8, IL‐1β, and tumor necrosis factor (TNF) α, as well as T‐cell proliferation. In clinical practice, a proportion of RA patients do not respond adequately to CS therapy. On this basis, RA patients can be divided on clinical grounds and on the ability of CSs to inhibit concanavalin A (conA)‐induced peripheral blood T‐cell proliferation in vitro into CS‐sensitive (SS) and CS‐resistant (SR) subgroups. The in vitro defined SS and SR subgroups correlate with the clinical responses to CS therapy. The mechanisms of the SR in RA patients remain unknown but may include the following: dysregulation of CRα function, alterations in the intracellular signaling mechanisms and/or utilization of various other cellular activation pathways, perturbations of the cytokine milieu, and inhibition of lipocortin. In SR subjects, CSs fail to significantly inhibit conA‐induced IL‐2 and IL‐4 secretion and LPS‐induced IL‐8, IL‐1β secretion in vitro. CS therapy fails to reduce the circulating levels of IL‐8, IL‐1β, and TNFα in SR RA patients. Peripheral blood mononuclear cells (PBMCs) from SR significantly overexpress activated NF‐κB and IκBα. In vitro CSs fail to significantly inhibit conA‐induced NF‐κB activation in PBMCs from SR RA patients. Our preliminary observations show enhanced CRβ expression by PBMCs from SR RA patients. It is most likely that other molecular mechanisms such as enhanced AP‐1 expression are involved, and we currently are investigating such possibilities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1749-6632.2002.tb04200.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 87

Metadata

Authors
CHIKANZA, I. C.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2002-06
Volume
966
Issue
1
Pages
39-48
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W2052264640
Cited by
87
References
6
FWCI
4.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis: A Putative Role for the Corticosteroid Receptor β Isoform. https://app.cochat.ai/papers/10.1111/j.1749-6632.2002.tb04200.x
The paper
CHIKANZA, I. C. (2002). Mechanisms of Corticosteroid Resistance in Rheumatoid Arthritis: A Putative Role for the Corticosteroid Receptor β Isoform. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2002.tb04200.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.